To rule out Wilms tumour, aniridia, genitourinary anomalies and intellectual disability (WAGR) syndrome, array-CGH is commonly used to detect mutation involving the WT1 and PAX6 genes in children with aniridia (26, 61). This evidence concerns the gene PAX6 and aniridia.